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FUNCTIONAL CHARACTERIZATION OF ROLES OF HISTONE 
DEACETYLASES IN THE REGULATION OF DNA DAMAGE RESPONSE 
ZHIGANG YUAN 
ABSTRACT 
 
Histone deacetylases (HDACs) are a family of enzymes whose functions have 
been overwhelmingly associated with gene expression and chromatin dynamics 
by modifying the histone tails. In recent years, intensive studies have 
demonstrated that many non-histone proteins also could serve as substrates for 
HDACs. And their functions and activities have been found to be regulated by 
posttranslational acetylation on the ε-amino group of lysines. Here, we report that 
two DNA repair factors including NBS1 (Nijmegen breakage syndrome 1) and 
ATDC (Ataxia-Telangiectasia Group D Complementing) are acetylated proteins. 
SIRT1 could maintain NBS1 in a hypoacetylated state, which is required for 
ionizing radiation-induced NBS1 Ser343 phosphorylation. And by modulating the 
acetylation of ATDC, HDAC9 could prevent ATDC-p53 complex formation, 
promoting IR-induced cell death. These data suggest HDACs play much wider 
roles in cells in addition to their transcriptional repression function. 
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SECTION I 
SIRT1 REGULATES THE FUNCTION OF THE NIJMEGEN BREAKAGE 
SYNDROME PROTEIN 
Abstract 
 
MRE11-RAD50-NBS1 (MRN) is a conserved nuclease complex that exhibits 
properties of a DNA damage sensor and is critical in regulating cellular 
responses to DNA double-strand breaks.  NBS1, which is mutated in the human 
genetic disease Nijmegen breakage syndrome, serves as the regulatory subunit 
of MRN.  Phosphorylation of NBS1 by the ATM kinase is necessary for both 
activation of the S-phase checkpoint and for efficient DNA damage repair 
response.  Here, we report that NBS1 is an acetylated protein and that the 
acetylation level is tightly regulated by the SIRT1 deacetylase.  SIRT1 associates 
with the MRN complex and, importantly, maintains NBS1 in a hypoacetylated 
state, which is required for ionizing radiation-induced NBS1 Ser343 
phosphorylation.  Our results demonstrate the presence of crosstalk between two 
different posttranslational modifications in NBS1 and strongly suggest that 
deacetylation of NBS1 by SIRT1 plays a key role in the dynamic regulation of the 
DNA damage response and in the maintenance of genomic stability. 
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Introduction 
Nijmegen breakage syndrome (NBS) is a rare autosomal recessive condition of 
chromosomal instability that is clinically manifested by symptoms including 
microcephaly, a distinct facial appearance, growth retardation, 
immunodeficiency, radiation sensitivity, and a strong predisposition to lymphoid 
malignancy (van der Burgt et al., 1996; Shiloh, 1997; Digweed and Sperling, 
2004).  Cells from NBS patients exhibit radiation hypersensitivity, radioresistant 
DNA synthesis (RDS), chromosomal instability, and cell cycle checkpoint defect 
(Tauchi et al., 2002).  Mutations in NBS1 (also known as nibrin or p95), the 
product of the Nijmegen breakage syndrome gene, are responsible for NBS 
(Varon et al., 1998).  The N-terminus of NBS1 protein contains a forkhead-
associated (FHA) domain adjacent to a breast cancer carboxy-terminal (BRCT) 
domain, both of which are commonly found in cell cycle checkpoint proteins.  The 
C-terminus of NBS1 is required for induction of MRN complex-mediated 
apoptosis in response to irradiation (Stracker et al., 2007). 
The ATM protein kinase, a multi-tasking DNA damage sensor, is mutated 
in individuals with the radiosensitivity disorder ataxia-telangiectasia.  Following 
cellular exposure to ionizing radiation (IR), ATM undergoes rapid 
autophosphorylation at Ser1981, resulting in the conversion of the inactive dimer 
form to active monomers (Bakkenist and Kastan, 2003).  Activated ATM 
phosphorylates a number of cellular substrates including NBS1 (Lim et al., 2000; 
Wu et al., 2000; Zhao et al., 2000).  NBS1 associates with MRE11 and RAD50 to 
form a protein complex (MRN complex) involved in detection, signaling, and 
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repair of DNA damage.  Using an Nbs1 knockout cell line, NBS1 was shown to 
be essential for homologous recombination DNA repair in vertebrate cells 
(Tauchi et al., 2002).  Although phosphorylation of NBS1 does not affect MRN 
association, this modification is functionally important since mutant NBS1 
(S343A) cannot completely complement radiosensitivity in cell lines lacking 
functional NBS1 (NBS cells) (Gatei et al., 2000; Lim et al., 2000; Zhao et al., 
2000).  In addition to serving as a downstream effector of ATM, NBS1 may 
function in activating ATM (Cerosaletti et al., 2006; Lee and Paull, 2005; You et 
al., 2005).  In fact, NBS1 phosphorylation may be required for activation of the S-
phase checkpoint by stimulating ATM-mediated phosphorylation of Chk2 (Lee 
and Paull, 2004). 
Besides phosphorylation, the functions and activities of an increasing 
number of proteins have been found to be regulated by posttranslational 
acetylation on the ε-amino group of lysines (Glozak et al., 2005; Kouzarides, 
2000; Yang, 2004).  This modification prevents positive charges from forming on 
the amino group of lysines and, as a result, has a significant impact on the 
electrostatic properties of the protein.  Over thirty proteins have been reported to 
possess lysine acetyltransferase activity, and many of these enzymes were first 
thought to specifically acetylate histones, but later were found to have a wide 
range of protein substrates in addition to histones (Sterner and Berger, 2000; 
Roth et al., 2001; Yang, 2004).  Also, many acetyltransferases, including p300, 
CBP (CREB-binding protein), and PCAF (p300/CBP-associated factor) are 
transcriptional co-activators. 
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Like many covalent protein modifications, posttranslational lysine 
acetylation is highly reversible, and increasing evidences suggest that 
acetylation/deacetylation, like phosphorylation, is important in the regulation of a 
number of biological processes (Kouzarides, 2000).  Thus, in order to fully 
understand the pathways that modulate the functions of NBS1, it is important to 
determine whether NBS1 undergoes acetylation and if so, whether this 
modification is reversibly regulated by deacetylation. 
Histone deacetylases (HDACs) are enzymes that catalyze the removal of 
acetyl moieties from the ε-amino groups of conserved lysine residues in the 
amino terminal tail of histones.  The removal of this modification strengthens 
histone-DNA interactions and may generate specific docking surfaces for 
proteins that regulate chromatin folding and/or transcription.  Results from 
numerous studies overwhelmingly support the prediction that HDACs play crucial 
roles in gene transcription and most likely affect all eukaryotic biological 
processes that involve chromatin.  Recent studies have shown that many non-
histone proteins can serve as HDAC substrates and many HDACs, like histone 
acetyltransferases (HATs), regulate important biological processes that extend 
beyond histones and gene transcription (Glozak and Seto, 2005). 
In humans, HDACs are divided into three categories:  the class I RPD3-
like proteins (HDAC1, HDAC2, HDAC3, HDAC8); the class II HDA1-like proteins 
(HDAC4, HDAC5, HDAC6, HDAC7, HDAC9, and HDAC10); and the class III 
Sir2-like proteins (SIRT1, SIRT2, SIRT3, SIRT4, SIRT5, SIRT6, and SIRT7).  
The class III proteins do not exhibit any sequence similarity to the other HDAC 
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family members and differ from the other HDACs in that they require the cofactor 
NAD+ for activity.  Whereas the NAD+-dependent class III deacetylases are 
specifically inhibited by nicotinamide, class I and II HDACs are specifically 
sensitive to the inhibitor tricohostatin A (TSA). 
Of the seven human Sir2-like proteins (sirtuins), SIRT1 is most similar to 
the yeast Sir2 protein, which is the prototypic class III HDAC (Guarente, 2006; 
Blander and Guarente, 2004).  In vitro, SIRT1 preferentially deacetylates 
histones H4K16 and H3K9, interacts with and deacetylates histone H1 at K26, 
and may mediate heterochromatin formation (Vaquero et al., 2004).  Besides 
histones, more than a dozen nonhistone proteins have been found to serve as 
substrates for SIRT1 (Blander and Guarente, 2004; Haigis and Guarente, 2006).  
SIRT1 regulates the tumor suppressor protein p53 and FOXO3 to suppress 
apoptosis and promote cell survival (Brunet et al., 2004; Giannakou and 
Partridge, 2004; Luo et al., 2001; Vaziri et al., 2001).  SIRT1 plays a role in 
several biological processes including stress resistance, metabolism, 
differentiation, and aging (Haigis and Guarente, 2006).  In addition, thymocytes 
derived from mice lacking SIRT1 exhibit increased sensitivity to 　-irradiation 
(Cheng et al., 2003). 
In the present study, we show that the NBS1 protein is acetylated.  
Furthermore, we found that SIRT1 binds to and deacetylates NBS1 in vitro and in 
vivo and, importantly, maintains NBS1 in a hypoacetylated state that is required 
for IR-induced NBS1 phosphorylation.  Induction of NBS1 hyperacetylation 
greatly reduces NBS1 phosphorylation.  Consistent with the importance of 
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hypoacetylated NBS1 in DNA damage repair, cell survival decreases and RDS 
increases in NBS1-deficient cells complemented with hyperacetylated NBS1.  
Together, our findings strongly implicate crosstalk between two different 
posttranslational modifications in the function of NBS1.  Additionally, our results 
uncovered NBS1 as a substrate for SIRT1 and provide convincing evidence that 
SIRT1 acts upstream of NBS1. 
Materials and Methods 
Plasmids, Antibodies, and Viruses 
The following expression plasmids used in these experiments have been 
described previously: pcDNA3-Myc-NBS1 (Maser et al., 2001), HA-NBS1 (Lim et 
al., 2000), Flag-ATM (Lim et al., 2000), Flag-PCAF (Yang et al., 1996), HA-p300 
(Aizawa et al., 2004), pRc/RSV-HA-CBP (Zhang et al., 2000), Flag-SIRT1-7 
(Michishita et al., 2005; North et al., 2003), Myc-SIRT1 (Langley et al., 2002), 
GST-SIRT1 (Langley et al., 2002), and Myc-SIRT1(H363Y) (Langley et al., 2002). 
The plasmid encoding Myc-NBS1mt was generated using the QuickChange Site-
Directed Mutagenesis kit following the manufacturer’s protocol (Stratagene). 
Plasmids encoding GST-NBS1 deletion mutants were created by inserting PCR 
products of NBS1 fragments into Bam H1/Not 1 digested pGEX-5X-1 vectors 
(Amersham). pBS/U6-SIRT1 was constructed by inserting oligodeoxynucleotides, 
which targeted the sequence 5’GAAGTTGACCTCCTCATTGT3’ into the pBS/U6 
vector (Sui et al., 2002). SIRT1 siRNA and control siRNA adenoviruses were 
described previously (Rodgers et al., 2005). Plasmids that express Myc-tagged 
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NBS1 lysine to glutamine mutants (5KQ: K544Q/K665Q/K690Q/K698Q/K715Q; 
7KQ: K441Q/K504Q/K544Q/K665Q/K690Q/K698Q/K715Q; 9KQ: 
K233Q/K334Q/K441Q/K504Q/K544Q/K665Q/K690Q/K698Q/K715Q; 10KQ: 
K208Q/K233Q/K334Q/K441Q/K504Q/K544Q/K665Q/K690Q/K698Q/K715Q) 
were generated by standard PCR and subcloning. 
Mouse affinity purified monoclonal anti-Flag M2, rabbit affinity purified 
polyclonal anti-HA, and mouse monoclonal anti-acetylated-tubulin (clone 6-11B-1) 
antibodies were purchased from Sigma. Mouse monoclonal anti-c-Myc (clone 
9E10) and mouse monoclonal anti-p53 (clone DO-1) antibodies were purchased 
from Santa Cruz Biotechnology. Rabbit polyclonal anti-hNBS1, rabbit polyclonal 
anti-phosphorylated-Ser343-hNBS1, rabbit polyclonal anti-phosphorylated-
Ser343-mNbs1, and rabbit polyclonal anti-ATM were purchased from Novus 
Biologicals. Mouse monoclonal anti-hNBS1 (clone 34) was purchased from BD 
Biosciences. Protein A purified mouse monoclonal anti-phosphorylated-Ser1981-
ATM (clone 10H11.E12) was purchased from Rockland Immunochemicals. 
Mouse monoclonal anti-hNBS1 (clone 1C3), mouse monoclonal anti-MRE11 
(clone 12D7), and mouse monoclonal anti-RAD50 (clone 13B3) were purchased 
from GeneTex. Rabbit polyclonal anti-acetyl-lysine, rabbit polyclonal anti-SIRT1, 
and mouse monoclonal anti-GST (clone DG122-2A7) antibodies were purchased 
from Upstate (Millipore). Mouse monoclonal anti-BrdU (clone BMC9318) was 
purchased from Roche. Rabbit polyclonal anti-acetylated-Lys382-p53 was 
purchased from Cell Signaling Technology. 
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Cell Culture, Transfection, and Adenovirus Infection 
Sirt1+/- mice were time-mated to screen for homozygous Sirt1-/- mutant embryos 
by PCR.  MEFs were generated from 13.5 dpc embryos using standard methods.  
HeLa, 293T, and murine Sirt1+/+ and Sirt1-/- fibroblasts were grown in Dulbecco’s 
modified Eagle’s medium (DMEM) supplemented with 10% fetal calf serum 
(FCS) and penicillin/streptomycin (pen/strep).  The NBS cell line (GM07166) was 
obtained from Coriell Cell Repository and grown in minimum essential medium 
(MEM) with 10% FCS and pen/strep.  All transfections were normalized with 
equal amounts of parental vector DNA.  Transfections were performed with 
Lipofectamine 2000 (Invitrogen) according to the manufacturer’s instructions.  To 
generate stable cell lines, NBS cells (GM 07166) transfected with vector alone or 
various expression plasmids were grown in the presence of G418 (200 mg/ml, for 
cells that received NBS1 expression plasmids) and puromycin (0.5 mg/ml, for 
cells that received PCAF expression plasmids) for 10 days.  Resistant colonies 
were isolated, pooled together, and grown for further analysis.  For viral infection, 
HeLa cells were infected with adenovirus for 24 h in DMEM with 0.5% BSA as 
previously described (Rodgers et al., 2005). 
 
Immunoprecipitation and Western Blot Analysis 
For immunoprecipitations, cells were lysed in buffer (50 mM Tris-HCl [pH 7.5], 1 
mM EDTA, 1% NP-40, and protease inhibitor cocktail) containing either 500 mM 
NaCl (high stringency) or 150 mM NaCl (low stringency).  The lysates were 
incubated with the primary antibody overnight at 4oC.  The resultant 
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immunocomplexes were collected, washed four times in lysis buffer, and 
resolved by SDS-PAGE.  For immunoblotting, samples were transferred onto 
nitrocellulose membranes.  Membranes were probed with the appropriate 
antibodies.  Proteins of interest were visualized using the Chemiluminescent 
Detection Kit (Pierce). 
 
Ion Trap Mass Spectrometry 
293T cells were transfected with the Myc-NBS1 expression plasmid and treated 
with TSA (1.3 M　 ) and nicotinamide (20 mM) overnight.  The cells were then 
lysed in high stringency buffer containing 10 mM NaB and 10 mM nicotinamide.  
Cell extracts were subjected to immunoprecipitation with anti-Myc antibodies.  
The immune complexes were resolved by SDS-PAGE and stained with colloidal 
Blue (Invitrogen).  The Myc-NBS1 sequence was analyzed with an in-house 
algorithm (EnzOpt) for a dual enzyme strategy maximizing proteotypic peptide 
coverage of all lysines.  The appropriate Myc-NBS1 gel band was excised and 
divided into two parts.  Each part was subjected to in-gel reduction and 
carboxyamidomethylation followed by separate tryptic or chymotryptic digestion.  
Acetylated peptides from each digest were detected and sequenced using 
microcapillary reverse-phase HPLC nano-electrospray tandem mass 
spectrometry (LC-MS/MS) on a Thermo LTQ linear quadrupole ion trap mass 
spectrometer.  Data analysis was facilitated with SEQUEST and the Proteomics 
Browser Suite (Thermo). 
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GST Pull-Down Assay 
GST and GST-NBS1 deletion mutants were expressed and purified from bacteria 
using standard methods.  Equimolar quantities of the various purified proteins 
were conjugated to glutathione-Sepharose beads and incubated with HeLa whole 
cell lysates for 1 h at 4°C.  After extensive washing, bound proteins were eluted 
and analyzed by Western blotting with anti-SIRT1 antibodies. 
 
In Vitro Deacetylation Assay 
In vitro deacetylation of NBS1 by SIRT1 was performed using an approach 
similar to that used previously for detection of PGC-1  acetylation 　 (Nemoto et 
al., 2005). 
 
RDS Assay 
The RDS assay was performed as described previously (Zhao et al., 2000) with 
minor modifications.  Briefly, NBS cells were transfected with either pEGFP-C3 
(Clontech) or pEGFP-C3 and the Myc-NBS1 expression plasmid at a ratio of 
1:10.  In some experiments, cells were also transfected with an additional 
plasmid encoding Flag-PCAF.  Cells were γ-irradiated with 15 Gy, incubated for 1 
h at 37oC, and then incubated for an additional 2 h in a medium containing 100 
M of BrdU.  BrdU incorporation was detected using an anti　 -BrdU antibody 
following immunostaining procedures described previously (Zhang et al., 2004). 
 Alternative RDS assays were performed as described by Lim et al. (2000) 
and by Zhao et al. (2002).  Briefly, cells were labeled for 24 h in medium 
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containing 10 nCi/ml of 14C-thymidine.  The cells were washed once with PBS 
and then incubated for 24 h in a nonradioactive medium.  After treatment with IR 
or left untreated, cells were incubated at 37°C for 30 min and pulse-labeled for 30 
min in a medium containing 2.5 mCi/ml of 3H-thymidine.  Cells were then washed 
with PBS and lysed with 0.5 ml of 0.2 M NaOH.  Radioactivity was quantified in a 
liquid scintillation counter, and the resulting ratios of 3H/14C were calculated and 
compared with ratios of non-irradiated cells. 
 
Colony Survival Assay 
Colony survival assays were performed as previously described (Zhao et al., 
2002) with minor modifications.  Briefly, NBS cells were plated in quadruplicate 
(1,000 cells per 60-mm tissue culture dish).  The cells were γ-irradiated with 0, 2, 
or 5 Gy.  After two weeks, dishes were washed with PBS, fixed in ice-cold 
methanol for 15 min, and then stained with Giemsa stain for 30 min.  Colonies on 
each plate were quantified and expressed as the percentage of the unirradiated 
control. 
Results 
NBS1 is an Acetylated Protein 
The NBS1 protein (accession BAA28616) contains three lysine acetylation 
consensus motifs, Kx1-2x/KK (Yang, 2004), at residues 233-237 (KGHKK), 683-
687 (KNFKK), and 686-690 (KKFKK).  Thus, in addition to phosphorylation, 
NBS1 is potentially modified by posttranslational lysine acetylation.  To determine 
if NBS1 is indeed a substrate for acetyltransferases, 293T cells were co-
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transfected with plasmids expressing a Myc-tagged NBS1 protein and three 
different acetyltransferases (PCAF, p300, or CBP).  Acetylated NBS1 was readily 
detected in cells that overexpressed PCAF or p300 but not in cells that 
overexpressed CBP (Figure 1A).  The level of NBS1 acetylation by PCAF was 
dose-dependent (Figure 1B).  Analysis of purified Myc-NBS1 by LC tandem mass 
spectrometry (LC-MS/MS) revealed that 10 of the 70 lysine residues were 
acetylated.  These included K208, K233, K334, K441, K504, K544, K665, K690, 
K698, and K715 (Figure 1C).  Mutation of all ten sites from lysine to arginine 
resulted in a dramatic decrease in the overall NBS1 acetylation levels as 
determined by Western blot analysis with anti-acetyl-lysine antibodies (Figure 
1D).  A small amount of residual acetylation can still be detected by Western 
blotting with anti-acetyl-lysine antibodies, suggesting that there could be minor 
acetylation sites that escaped mass spectrometry analysis. 
 
Class III HDACs Regulate NBS1 Acetylation Level 
To examine whether NBS1 might be regulated by deacetylation, we 
immunoprecipitated Myc-NBS1 from 293T cells treated with HDAC inhibitors.  As 
shown in Figure 1E, treatment of cells with TSA, a class I and II HDAC inhibitor, 
did not affect the acetylation status of NBS1.  In contrast, cells treated with 
nicotinamide, a class III (Sir2 family) HDAC inhibitor, resulted in a notable 
increase in acetylation of NBS1.  Treatment with a combination of TSA and 
nicotinamide was not associated with any additional increase in NBS1 acetylation  
 
 
A B
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Figure 1.  NBS1 is Acetylated 
(A) 293T cells were co-transfected with equal amounts (4ug) of Myc-NBS1 ± one of the following expression plasmids: 
Flag-PCAF, HA-p300, or HA-CBP.  Cell lysates were immunoprecipitated (IP) under high stringency conditions using anti-
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Myc antibodies.  Immunoprecipitates were subjected to Western blot (IB) analysis using anti-acetyl-lysine (AcK) 
antibodies.  The blot was stripped and re-probed with anti-Myc antibodies to confirm equal immunoprecipitation efficiency 
and loading.  As CBP (but not PCAF) is known to acetylate p53-K382, a Western blot was performed with anti-AcK382-
p53 to confirm that the expressed CBP was functional.  (B) 293T cells were co-transfected with Myc-NBS1 (4 ug) and 
Flag-PCAF (0, 0.5, 1, or 4 ug).  Cell lysates were subjected to immunoprecipitation/Western blot analysis using the 
indicated antibodies.  Western blot analysis of whole extracts was performed to assess PCAF expression (bottom panel).  
(C) Myc-NBS1, which was expressed and purified from 293T cells, was digested with trypsin and subjected to ITMS.  
Positions of the unambiguously-identified acetylated lysine residues are shown.  FHA, forkhead-associated domain; 
BRCT, BRCA1 C-terminal domain; MIR, MRE11-interacting domain; AIR, ATM-interacting domain.  (D) 293T cells were 
co-transfected with Myc-NBS1 (wild-type or lysine to arginine mutant [mt]) and Flag-PCAF (4 ug each), as indicated.  
Total and acetylated NBS1 levels were analyzed by immunoprecipitation/Western blotting.  (E) 293T cells were 
transfected with plasmids that expressed Myc-NBS1 (4 ug).  Twenty-four hours post-transfection, cells were left untreated 
or treated overnight with TSA (1.3 uM), nicotinamide (20 mM), or TSA plus nicotinamide.  Cell lysates were subjected to 
immunoprecipitation/Western blotting.  Whole cell extracts were probed with anti-Ac-tubulin and anti-Ac-H4K16 to confirm 
that TSA is functional under the treatment condition (lower panels).  (F) 293T cells were transfected with plasmids (4 ug 
each) expressing wild-type or mutant Myc-NBS1 as indicated and then treated with 20 mM nicotinamide overnight.  Myc-
NBS1 acetylation and protein expression were examined by immunoprecipitation/Western blotting.  (G) HeLa cells were 
treated with nicotinamide (20 mM) or left untreated overnight.  Cell lysates were then immunoprecipitated under high 
stringency conditions with monoclonal anti-NBS1 antibodies.  Endogenous acetylated NBS1 was analyzed by Western 
blotting with a mixture of polyclonal anti-acetyl-lysine antibodies. 
 
when compared to treatment with nicotinamide alone.  Thus, NBS1 might be 
deacetylated by class III HDACs but not by class I or II HDACs.  Hyperacetylation  
of NBS1 is specific to nicotinamide treatment since the NBS1-acetylation mutant 
did not respond to this HDAC inhibitor (Figure 1F).  Anti-acetyl-lysine Western 
blot analysis of anti-NBS1 immunoprecipitates obtained under high stringency 
conditions in which neither MRE11 nor RAD50 co-precipitated with NBS1, 
revealed that nicotinamide enhanced the acetylation state of endogenous NBS1 
(Figure 1G), providing proof that endogenous NBS1 is regulated by class III 
HDACs. 
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NBS1 Interacts with SIRT1 
An interesting feature of the class III HDACs is their subcellular location 
(Michishita et al., 2005).  SIRT1, SIRT6, and SIRT7 are present in the nucleus 
while SIRT2 is located in the cytosol despite the possibility of deacetylating 
H4K16 during mitosis (Vaquero et al., 2006).  SIRT3, SIRT4, and SIRT5 are 
localized in the mitochondria.  Of the three nuclear SIRTs, SIRT1 has been 
shown to possess robust deacetylase enzymatic activity, while SIRT6 and SIRT7 
have been reported to have very weak or no deacetylase activity (Liszt et al., 
2005; North et al., 2003).  Therefore, SIRT1 is likely responsible for the 
deacetylation of NBS1. 
Since most, if not all, deacetylase substrates interact with their respective 
enzymes, we first tested the ability of NBS1 to interact with SIRT1.  As shown in 
figure 2A, Flag-SIRT1 co-precipitated with Myc-NBS1.  Similarly, Myc-NBS1 co-
precipitated with Flag-SIRT1 (Figure 2B).  The SIRT1-NBS1 interaction is highly 
specific since none of the other Sir2 family members (SIRT2, SIRT3, SIRT4, 
SIRT5, SIRT6, or SIRT7) co-precipitated with NBS1 under identical conditions 
(Figure 2C).  This association of SIRT1 and NBS1 also occurs in the absence of 
overexpression, epitope tagging of either protein, or IR treatment (Figure 2D).  
Because the subunits of the MRN complex most likely do not act individually, 
MRE11 and RAD50 also co-precipitated with SIRT1 as expected, suggesting that 
SIRT1 associates with the whole MRN complex.  Analyses of three different 
GST-NBS1 deletions indicated that SIRT1 interacts with the C-terminus of NBS1  
 
 A C
+ Input - - - Flag-SIRT1 - + - - - -- - 
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Figure 2.  SIRT1 Interacts With NBS1 
(A, B, C) 293T cells were co-transfected with plasmids (4ug each) encoding the indicated Myc and Flag fusion proteins.  
Anti-Myc and anti-Flag immunoprecipitates obtained under low stringency conditions were analyzed by Western blotting 
with the indicated antibodies.  (D) HeLa cells were irradiated (10 Gy) or left untreated.  One hour after irradiation, 
endogenous SIRT1 was immunoprecipitated under low stringency conditions with anti-SIRT1 polyclonal antibodies.  
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Immune complexes were analyzed by Western blotting with anti-NBS1, anti-MRE11, anti-RAD50, or anti-SIRT1 
antibodies.  For maximum clarity, the image gathered for the left upper middle panel (MRE11, lanes 1 and 2) was under-
exposed compared to the right upper middle panel (MRE11, lanes 3-6).  (E) GST-NBS1 deletion mutants coupled to 
Sepharose beads were incubated with whole HeLa cell extracts.  After the beads were washed, bound proteins were 
eluted and analyzed by Western blotting with an anti-SIRT1 antibody.  The blot was stripped and re-probed with anti-GST 
antibodies to confirm equal quantities of GST proteins in each reaction. 
 
(residues 572-754), a segment that contains the MRE11 and ATM interaction 
region (Figure 2E). 
 
SIRT1 Deacetylates NBS1 
To test whether SIRT1 deacetylates NBS1, we examined the effect of RNAi-
mediated SIRT1 knockdown on NBS1 acetylation in 293T cells.  BS/U6-
templated siRNA efficiently silenced expression of SIRT1 but not the control 
protein β-actin, as monitored by Western blot analysis (Figure 3A).  In agreement 
with the finding that SIRT1 binds NBS1, acetylation of both Myc-NBS1 (Figure 
3A) and endogenous NBS1 (Figure 3B) was significantly increased as a result of 
SIRT1 knockdown.  Unlike knock-down of SIRT1, depletion of SIRT6 or SIRT7 
did not affect NBS1 acetylation levels (Figure 3C).  Furthermore, PCAF-
acetylated NBS1 was deacetylated by wild-type SIRT1 (Figure 3D), but not by a 
catalytic-defective SIRT1 mutant (H363Y) (Figure 3D) or by SIRT2, SIRT3, 
SIRT4, SIRT6, SIRT7 (Figure 3E).  In vitro deacetylation assays using purified 
SIRT1 in the presence of NAD+ further confirmed that NBS1 is a substrate of 
SIRT1 (Figure 3F).  Collectively, our data strongly suggest that SIRT1 modulates 
the acetylation status of NBS1 via its deacetylase activity. 
  A B
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Figure 3.  SIRT1 Deacetylates NBS1 
(A) 293T cells were co-transfected with equal amounts (4 ug) of Myc-NBS1 plasmid and either a plasmid encoding 
pBS/U6-SIRT1 or control siRNA.  Western blots were performed with the indicated antibodies to assess the levels of 
SIRT1, β-actin, total Myc-NBS1, and acetylated Myc-NBS1.  (B) 293T cells were infected with either adenovirus that 
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expresses control siRNA or adenovirus that expresses SIRT1 siRNA.  Western blots were performed with the indicated 
antibodies to assess the acetylation of endogenous NBS1 and NBS1 immunoprecipitation efficiency.  (C) Top two panels, 
293T cells were co-transfected with equal amounts (4 ug) of Myc-NBS1 plasmid and either a plasmid encoding SIRT1 
siRNA, SIRT6 siRNA, SIRT7 siRNA, or control siRNA.  Western blots were performed with the indicated antibodies to 
assess the levels of total Myc-NBS1 and acetylated Myc-NBS1.  Bottom two panels, similar experiments were performed 
with over-expression of Flag-SIRT6 and Flag-SIRT7 to show that SIRT6 and SIRT7 siRNAs are functional.  (D) 293T cells 
were co-transfected with plasmids that express HA-NBS1, Flag-PCAF, and either a wild-type or a catalytically-defective 
Myc-SIRT1.  Acetylation of HA-NBS1 and all protein levels were determined with direct Western blotting or 
immunoprecipitations followed by Western blotting using the indicated antibodies.  (E) 293T cells were co-transfected with 
plasmids that express Myc-NBS1, Flag-PCAF, and different Flag-tagged SIRTs.  Acetylation of Myc-NBS1 and all protein 
levels were determined with direct Western blotting or immunoprecipitations followed by Western blotting using the 
indicated antibodies.  (F) 293T cells were transfected with Myc-NBS1 and Flag-PCAF.  Anti-Myc immunoprecipitates were 
incubated with recombinant GST-SIRT1 in the absence or presence of NAD+ (lane 2, 1mM; lane 3, 10 mM) and 
nicotinamide (10 mM) at 30oC for 1 h.  Western blot analysis of acetylated Myc-NBS1 was then performed using anti-
acetyl-lysine (AcK) antibodies. 
 
Acetylation Inhibits NBS1 Phosphorylation 
The balance between acetylation and deacetylation may have functional 
consequences for NBS1.  Previous work has shown that ATM-mediated 
phosphorylation of NBS1 at Ser343 in response to DNA damage is critical for the 
DNA damage responses and for activation of the cell cycle S-phase checkpoint 
(Lim et al., 2000; Wu et al., 2000; Zhao et al., 2000).  We hypothesized that 
different posttranslational modifications of NBS1 affect the phosphorylation of 
NBS1 at Ser343.  NBS cells (GM07166) expressing Myc-NBS1 alone or in 
combination with Flag-PCAF were irradiated, and the time course of NBS1 
Ser343 phosphorylation was examined via Western blot analysis.  As shown in 
Figure 4A, overexpression of PCAF, which acetylates NBS1, reduced the levels 
of NBS1 phosphorylation at all times examined.  Similar results were obtained 
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Figure 4.  NBS1 Acetylation Status Affects IR-induced NBS1 Phosphorylation 
(A) The NBS cell line GM07166 was transfected with equal amounts (4 ug) of Myc-NBS1 expression plasmid and Flag-
PCAF expression plasmid or empty vector.  Twenty-four hours post-transfection, cells were irradiated (6 Gy) or left 
untreated.  Cell lysates were subjected to Western blot analysis or to high stringency immunoprecipitation/Western blot 
analysis, as indicated.  (B) NBS cells transfected with Myc-NBS1 expression plasmid (4 ug) were treated overnight with 
20 mM of nicotinamide or left untreated.  The cells were then irradiated (6 Gy) or left untreated.  Cell lysates were 
prepared after the indicated time and subjected to direct Western blot analysis or high stringency 
immunoprecipitation/Western blot analysis using the indicated antibodies.  (C) To examine the effect of nicotinamide on 
ATM-NBS1 interactions, ATM and NBS1 were immunoprecipitated with anti-ATM antibodies and anti-NBS1 antibodies, 
respectively, from extracts prepared from HeLa cells treated ± nicotinamide.  NBS1 and ATM were identified in the 
immunoprecipitates by Western blotting with anti-NBS1 and anti-ATM, respectively.  (D) NBS cells were transfected with 
plasmids encoding either wild-type or acetylation-defective Myc-NBS1 (4 ug).  Parallel cultures were then irradiated or left 
unirradiated in the presence or absence of nicotinamide.  Lysates were analyzed by Western blots with the indicated 
antibodies.  (E) NBS cells were transfected with plasmids encoding either wild-type Myc-NBS1 or acetylation-mimic Myc-
NBS1 mutants (4　ug).  Parallel cultures were then irradiated or left unirradiated and lysates were analyzed by Western 
blots with the indicated antibodies. 
 
when NBS cells, complemented with Myc-NBS1, were treated with nicotinamide 
to induce NBS1 hyperacetylation (Figure 4B).  The decrease in NBS1 Ser343 
phosphorylation was not due to a decrease in ATM protein levels (Figures 4A 
and 4B), a decrease in activated ATM (as measured by phospho-S1981 of ATM; 
Figures 4A and 4B), or a decrease in ATM-NBS1 interaction (Figure 4C).  
Treatment with nicotinamide had no effect on NBS1 Ser343 phosphorylation in 
an NBS1 mutant that was refractory to acetylation/deacetylation (Figure 4D). 
 To further examine the effect of acetylation/deacetylation on NBS1 Ser343 
phosphorylation, we constructed four plasmids that express NBS1 acetylation-
mimic mutants, with lysine to glutamine changes, and introduced them into NBS 
cells.  As shown in Figure 4E, consistent with our observation that acetylation of 
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NBS1 inhibits phosphorylation of NBS1, mutation of lysine to glutamine in NBS1 
resulted in a significant decrease in NBS1 Ser343 phosphorylation.  Importantly, 
the decrease in NBS1 phosphorylation is strictly proportional to the number of 
lysine mutations (i.e., the more lysine to glutamine change, the more decrease in 
NBS1 phosphorylation). 
 
Presence of SIRT1 Affects NBS1 phosphorylation 
Because SIRT1 is the chief regulator of the acetylation status of NBS1 (Figure 3), 
we determined whether NBS1 Ser343 phosphorylation was directly affected by 
the presence of SIRT1.  As shown in Figure 5A, Nbs1 Ser343 was 
hypophosphorylated in Sirt1-/- MEFs compared to wild-type MEFs.  Likewise, 
depletion of SIRT1 by siRNA resulted in a significant decrease in NBS1 Ser343 
phosphorylation (Figure 5B). 
 
Acetylation of NBS1 Affects RDS 
Although results from one study suggest that ATM phosphorylation of NBS1 
contributes to the formation of IR-induced foci in cells (Zhao et al., 2000), other 
studies convincingly demonstrated that NBS1 phosphorylation does not affect 
formation of IR-induced foci and that the MRN complex is recruited to foci 
independently of ATM (Lim et al., 2000).  We examined the ability of the NBS1 
acetylation-defective mutant to associate with MRE11 and RAD50 and found that 
no significant differences exist between mutant and wild-type NBS1 (Figure S1).  
Furthermore, no significant differences in NBS1 foci formation could be detected 
 A 
Sirt1+/+ + + - + - - B
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Figure 5.  Presence of SIRT1 affects NBS1 Ser343 phosphorylation 
(A) Murine Sirt1+/+ and Sirt1-/- fibroblasts were irradiated (6 Gy) or left unirradiated.  At different time points after IR, cell 
lysates were collected and analyzed by Western blotting with anti-pS343-mNbs1 antibodies.  The blot was sequentially 
stripped and re-probed with anti-mNbs1 and pS1981-ATM antibodies to confirm equal mNbs1 protein levels and intact 
ATM activation.  (B) 293T cells infected with adenoviruses expressing SIRT1 siRNA or control viruses were irradiated (6 
Gy) or left unirradiated.  At different time points after IR, cell lysates were collected and analyzed by Western blotting with 
anti-pS343-NBS1 antibodies.  The blot was stripped and re-probed with anti-NBS1. 
 
between Sirt1+/+ and Sirt1-/- MEFs following IR treatment (data not shown).  
Therefore, our data suggest that, similar to phosphorylation, acetylation of NBS1 
does not play a role in the recruitment of MRN to H2AX domains surrounding 　
DNA DSBs. 
Unlike IR-induced foci formation, phosphorylation of NBS1 is clearly 
involved in regulating the intra-S-phase checkpoint (Lim et al., 2000; Zhao et al., 
2000).  A common phenotype of NBS cells is the loss of the IR-induced S-phase 
checkpoint, leading to RDS.  Using an RDS assay, we examined the effects of 
NBS1 acetylation on cell cycle checkpoints activated by DNA damage.  NBS 
cells expressing Myc-NBS1 and enhanced green fluorescent protein (EGFP) 
were irradiated or mock-treated immediately after 25-bromodeoxyuridine (BrdU) 
treatment, and the ratios of BrdU-positive/EGFP-positive cells to EGFP-positive 
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cells were determined.  Compared to wild-type NBS1, PCAF-hyperacetylated 
NBS1 was ineffective at inhibiting RDS, suggesting that hypoacetylation of NBS1 
is crucial for intra-S-phase checkpoint activation (Figure 6A).  In contrast, PCAF 
did not alter the ability of the acetylation-refractory mutant NBS1 to inhibit RDS.  
Similarly, in control experiments, PCAF had no effect on the NBS1 
phosphorylation mutant (S343A) in inhibiting RDS.  Western blot analysis 
confirmed that Ser343 phosphorylation of wildtype (Myc-NBS1), but not the 
acetylation mutant (Myc-NBS1mt), decreased with increased acetylation in NBS 
cells. 
To be certain that NBS1 acetylation/deacetylation affects RDS, we 
transfected NBS cells (GM07166) with plasmids expressing wild-type or mutated 
NBS1, in the presence or absence of plasmids that express PCAF.  Stable 
clones were selected by growth in G418 plus or minus puromycin, and cells 
stably expressing NBS1 and/or PCAF were treated with IR and examined for 
DNA synthesis using radiolabeled thymidine.  Consistent with transient 
transfection results, acetylation of wild-type, but not acetylation-defective, NBS1 
by PCAF significantly reduced its ability to inhibit RDS (Figure 6B). 
Finally, consistent with observations that NBS1 hyperacetylation prevents 
its ability to inhibit RDS in transfected NBS cells, we found that Sirt1-/- MEFs, 
which contain hypophosphorylated and hyperacetylated Nbs1, display a higher 
level of RDS compared to Sirt1+/+ cells (Figure 6C). 
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Figure 6.  NBS1 Acetylation Affects Radioresistant DNA synthesis (RDS) 
(A) NBS cells were transfected with plasmids encoding the indicated proteins.  Twenty-four hours after transfection, cells 
were irradiated (15 Gy) or left unirradiated.  Left panel, RDS was determined by comparing the ratio of BrdU+/EGFP+ cells 
to EGFP+ cells.  The bar represents the ratio in the IR-treated cells divided by the ratio in the untreated cells.  Right 
panels, to assess immunoprecipitation efficiency, protein expression, and NBS1 acetylation/phosphorylation, cell lysates 
were subjected to Western blot analysis or to high stringency immunoprecipitation/Western blot analysis, as indicated.  
Representative blots are shown.  (B) Left panel, NBS cells (GM 07166) transfected with vector alone or the indicated 
expression plasmids were grown in the presence of G418 (200 mg/ml, for cells that received NBS1 expression plasmids) 
and puromycin (0.5 mg/ml, for cells that received PCAF expression plasmids) for 10 days.  Stable colonies were isolated, 
pooled together, and after treatment with 15 Gy of IR or left untreated, cells were radiolabeled with thymidine for RDS 
analysis.  Right panels, representative blots to monitor immunoprecipitation efficiency, protein expression, and NBS1 
acetylation/phosphorylation.  (C) 2 X 104 Sirt1+/+ or Sirt1-/- MEFs were plated on 35 mm dishes for 48 h.  RDS assays 
were performed using the radio-labeling method to determine inhibition of DNA synthesis after 15 Gy of IR. 
 
Acetylation of NBS1 Affects Cell Survival 
Unsuccessful DNA damage responses are reflected in an overall decrease in cell 
survival.  Therefore, clonogenic cell survival assays were employed to examine 
the importance of NBS1 acetylation in DNA damage responses.  NBS cells were 
exposed to a sublethal dose of IR, and colonies were counted two weeks later.  
Cell transfection and immunoprecipitation efficiency, protein expression levels, 
and NBS1/NBS1mt acetylation levels were monitored by immunoprecipitation 
followed with Western blots or by direct Western blots (Figure 7A).  Consistent 
with the finding that hyperacetylated NBS1 negatively affects cell cycle 
checkpoint activation, PCAF-hyperacetylated NBS1 was much less effective in 
reducing the IR sensitivity of NBS cells (increasing cell survival) than non-
hyperacetylated NBS1.  As expected, in the presence of PCAF, survival among  
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Figure 7.  NBS1 Acetylation Affects Cell Survival 
 
Left panel, NBS cells transfected with plasmids (4 ug each) encoding the indicated proteins were irradiated (2 Gy) or left 
unirradiated.  The surviving colonies were counted two weeks later.  Right panels, direct Western blots and high 
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stringency immunoprecipitation/Western blot analyses were performed to determine NBS1 acetylation, 
immunoprecipitation efficiency, and protein expression levels.  Representative blots are shown.  (C) Sirt1+/+ and Sirt1-/- 
MEFs were irradiated with the indicated dosage or left unirradiated.  The surviving colonies were counted two weeks later.  
Fractional cell survival is the fraction of colonies surviving irradiation divided by the total number of colonies in the 
unirradiated parallel culture.  The data are expressed as mean ± SD from three separate experiments. 
 
cells expressing mutant NBS1, which is less efficiently acetylated by PCAF, was 
higher compared to cells expressing wild-type NBS1. 
To confirm that hyperacetylation of NBS1 negatively affects cell survival, 
we repeated the colony survival assays in cells stably expressing wild-type or  
mutant NBS1 and PCAF.  As shown in Figure 7B, the presence of PCAF reduced 
the ability of wild-type NBS1 to increase cell survival after IR treatment in stably 
transfected NBS cells.  Likewise, in complementary experiments, the absence of 
Sirt1 decreased survival rate following γ-IR compared to wild-type MEFs (Figure 
7C). 
Discussion 
HATs and HDACs play critical roles in diverse biological functions.  In humans, 
two well-characterized HATs, hGCN5 and TIP60, play important roles in DNA 
repair (Brand et al., 2001; Ikura et al., 2000).  In the current study, we show that 
NBS1 can be acetylated by PCAF and p300 and that acetylation of NBS1 inhibits 
Ser343 phosphorylation.  At this time, the exact mechanism by which 
acetylation/deacetylation of NBS1 modulates phosphorylation is unclear.  One 
plausible model is that hypoacetylation of lysines on NBS1 induces an 
intramolecular structural change in NBS1 that favors phosphorylation.  Our data 
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clearly indicate that NBS1 acetylation results in a decrease in cell survival and an 
increase in RDS most likely due to decreased NBS1 phosphorylation.  
Mass spectrometry analysis of NBS1 indicated that ten of the 70 lysine 
residues in NBS1 were acetylated.  The NBS1 protein possesses three lysine 
acetylation consensus motifs, Kx1-2x/KK, (previously described by Yang, 2004), 
at residues 233-237 (KGHKK), 683-687 (KNFKK), and 686-690 (KKFKK).  
However, we found that only two out of the ten potential acetylation sites 
identified by sequence analysis were actually acetylated (residues 233 and 690).  
Moreover, eight other acetylation sites detected on NBS1 by mass spectrometry 
analysis do not conform to any consensuses.  Therefore, not only does substrate 
recognition by SIRT1 not dependent on the amino acid sequence proximate to 
the acetylated lysine (Blander et al., 2005), it appears that the NBS1 
acetyltransferase(s) similarly does not have strict sequence requirements. 
Although we cannot rule out the possibility that in addition to p300 and 
PCAF more acetyltransferases can modify NBS1, our data clearly demonstrate 
that NBS1 is deacetylated predominantly, if not exclusively, by SIRT1.  Our 
results are consistent with a model in which SIRT1 is required to maintain 
hypoacetylated NBS1, which promotes efficient IR-induced NBS1 
phosphorylation and the ensuing cellular responses to DNA damage.  Thus, an 
additional function of SIRT1 may be to maintain NBS1 in a constant 
hypoacetylated state.  Alternatively, IR may induce SIRT1 activity in order to 
regulate the acetylation status of NBS1; however, this possibility cannot be 
tested directly due to the low basal levels of acetylated NBS1.  Despite this 
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dilemma, these results are in accordance with the notion that SIRT1, in addition 
to silencing transcription, plays an important role in suppressing genomic 
instability and, consequently, in regulating aging in mammals (Lombard et al., 
2005). 
Many evidences suggest a close link between histone deacetylation and 
DNA repair.  For example, the yeast Sin3/Rpd3 complex has been shown to 
modulate DNA DSB repair through the deacetylation of histone H4K16 (Jazayeri 
et al., 2004).  The Sir2 and Rpd3 proteins are recruited to HO lesions during 
homology-directed repair (Tamburini and Tyler, 2005).  RPD3 and HOS2 are 
required for the activation of DNA damage-inducible genes RNR3 and HUG1 
(Sharma et al., 2007).  Furthermore, HDAC4 is recruited to DSBs in vivo and, 
therefore, is implicated in DNA repair in mammalian cells (Kao et al., 2003).  
Knockdown of HDAC4 expression by RNAi increases radiosensitivity and blocks 
G2/M checkpoint maintenance.  Also, it was reported that the SMRT-HDAC3 
complex is involved in cellular recovery from DNA DSBs in mammalian cells (Yu 
et al., 2006).  SMRT and HDAC3 are required for transcriptional repression by 
Ku70, a subunit of the DNA-PK DSB repair complex. 
Although p53 is known to be a substrate for SIRT1 (Luo et al., 2001; Vaziri 
et al., 2001), the contribution of SIRT1 to p53-mediated DNA damage repair is 
controversial.  While one study suggests that SIRT1 modulates p53-dependent 
DNA-damage responses (Chen et al., 2005), other reports argue that SIRT1 
does not affect p53-mediated biological activities (Kamel et al., 2006; Solomon et 
al., 2006).  More recently, SIRT6 was found to be a chromatin-associated protein 
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that promotes normal base excision repair but does not play a role in regulating 
cell cycle checkpoints (Mostoslavsky et al., 2006).  Our finding that SIRT1 
deacetylates NBS1 and is intimately involved in the regulation of the intra-S-
phase checkpoint, coupled with the recent report that DNA damage induces 
SIRT1 expression (Wang et al., 2006), raises the intriguing possibility that 
HDACs ensure genomic stability through a variety of mechanisms involving 
multiple pathways. 
In the MRN complex, besides acetylation/deacetylation and 
phosphorylation of NBS1, the activities and functions of MRE11 are regulated by 
posttranslational modifications.  MRE11 undergoes cell cycle-dependent 
phosphorylation in response to several genotoxic agents, and this modification 
requires NBS1 but not ATM (Dong et al., 1999; Yuan et al., 2002).  In addition, 
MRE11 is methylated at arginine residues by PRMT1, and mutation of the 
arginines severely impairs the exonuclease activity of MRE11 although the 
mutated protein still forms the MRN complex (Boisvert et al., 2005).  In sharp 
contrast to the hypoacetylation of NBS1, cells containing hypomethylated MRE11 
display intra-S-phase DNA damage checkpoint defects.  In preliminary studies, 
we found that MRE11, but not RAD50, is acetylated in the cell (data not shown).  
Because SIRT1 associates with the entire MRN complex, future studies are 
warranted to determine whether MRE11, like NBS1, is similarly regulated by 
SIRT1 and if so, whether acetylation/deacetylation of MRE11 interacts with other 
MRE11 modifications to ultimately affect the DNA DSB repair pathway. 
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SECTION II 
HISTONE DEACETYLASE 9 MODULATES CELL SURVIVAL  
BY REGULATING THE ATDC-P53 COMPLEX 
Abstract 
 
HDAC9 is a class II HDAC that acts as a signal-responsive suppressor of cardiac 
hypertrophy. Several proteins, most notably the myocyte enhancer-binding factor 
2 (MEF2), have been found to partner with HDAC9.  Through its interactions with 
MEF2, HDAC9 represses MEF2 activity. By using immunoaffinity 
chromatography, we have identified a novel HDAC9-interacting protein, ATDC, 
the product of the ataxia-telangiectasia group D complementing gene.  The 
ATDC gene was originally isolated on the basis of its ability to complement the 
ionizing radiation sensitivity defect of AT group D fibroblasts. We found that 
ATDC is an HDAC9 substrate and its biological functions are finely controlled by 
HDAC9. ATDC sequesters p53 in the cytoplasm, facilitating cell survival by 
antagonizing the p53-mediated apoptotic pathway following ionizing radiation.  
By modulating the acetylation of ATDC, HDAC9 prevents ATDC-p53 complex 
formation, promoting IR-induced cell death.  Importantly, we found that ATDC 
acetylation may also play important roles in regulating pancreatic and cervical 
carcinoma radiosensitivity and survival. Thus, our results have important 
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implications regarding clinical treatment for radio-resistant tumors caused by 
amplified expression of ATDC. 
Introduction 
Histone deacetylases (HDACs) are a family of enzymes whose functions have 
been overwhelmingly associated with gene expression and chromatin dynamics 
(Hassig and Schreiber, 1997; Kuo and Allis, 1998; Johnson and Turner, 1999; 
Peterson, 2002). 18 human histone deacetylases that share homology through 
their deacetylase domains have been characterized, and they may be broadly 
divided into three classes on the basis of homology to the yeast HDACs RPD3 
(class I), HDA1 (class II) and Sir2 (class III) (Gray and Ekstrom, 2001; Yang and 
Seto, 2003; Ruijter et al., 2003; Gregoretti et al., 2004; Marks et al., 2003). Class 
I HDACs consist of nuclear proteins that are generally small in size (40-55 kDa) 
and are ubiquitously expressed. In contrast, Class II HDACs are larger (ranging 
from 100 to 160 kDa), with expression patterns that tend to be tissue-specific 
(Ruijter et al., 2003; Marks et al., 2003). Recent studies have implicated the 
importance of HDACs in normal development and abnormal HDAC expression to 
have a function in a number of human diseases (Johnstone et al, 2003; Kramer 
et al., 2001).  
The gene encoding the HDAC9 protein is located on chromosome 7p21 
(Mahlknecht et al., 2002). The human HDAC9 open reading frame is 3036 bp 
long and encodes a 1011 a.a. protein with a predicted molecular weight of 111.3 
kDa and an isoelectric point of 6.41 (Zhou et al., 2001). The HDAC9 gene 
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encodes multiple protein isoforms, some of which display distinct cellular 
localization patterns (Petrie et al., 2003), and HDAC9 could shuttle between 
cytoplasm and nucleus (Zhou et al., 2001; Zhang et al., 2002). HDAC9 contains 
a conserved deacetylase domain, represses reporter activity when recruited to a 
promoter, and utilizes histones H3 and H4 as substrates in vitro and in vivo 
(Zhou et al., 2001; Petrie et al., 2003). HDAC9 is expressed in a tissue-specific 
pattern, most highly in heart tissue (Zhou et al., 2001; Zhang et al., 2002; Petrie 
et al., 2003). It was reported that HDAC9 could restrict cardiac growth in 
response to stress (Zhang et al., 2002).  
The ATDC (ataxia telangiectasia group D complementing) gene was originally 
identified by its ability to complement the radiosensitivity defect of a cell line 
(AT5BIVA) from the D complementation group of the autosomal recessive human 
genetic disease ataxia telangiectasia (AT) (Kapp et al., 1992; Leonhardt et al., 
1994). There are multiple zinc finger motifs and an adjacent leucine zipper motif 
in ATDC (Leonhardt et al., 1994). Endogenous and overexpressed ATDC protein 
locate in the cytoplasm (Laderoute et al., 1996; Brzoska et al., 1995; Reymond et 
al., 2001). ATDC gene is significantly amplified in human pancreatic and cervical 
carcinomas (Iacobuzio-Donahue et al., 2002; Zhang et al. 2005). Although ATDC 
could complement the radiosensitivity of cells, the underlying mechanisms and its 
role in tumorigenesis are largely unknown.    
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In the present study, we found that ATDC is an acetylated protein which is finely 
controlled by HDAC9. As a cytoplasmic protein, ATDC might facilitate cell 
survival by sequestering p53 in the cytoplasm and antagonizing the p53-
mediated apoptotic pathway following ionizing radiation. By modulating the 
acetylation of ATDC, HDAC9 could regulate the ATDC-p53 complex formation, 
promoting IR-induced cell death.  Importantly, ATDC acetylation may also play 
important roles in regulating pancreatic and cervical carcinoma radiosensitivity 
and survival. 
Materials and Methods 
Plasmids, Antibodies, and Viruses 
The following expression plasmids used in these experiments have been 
described previously:  Flag-HDAC9 (Zhou et al., 2001), Flag-HDAC9 isoforms 
(Petrie et al., 2003), Flag-PCAF (Yang et al., 1996), HA-p300 (Aizawa et al., 
2004), pRc/RSV-HA-CBP (Zhang et al., 2000), pC53-SN3 and BP-100 GL2 
(Peng et al., 2003), GST-p53 and its deletion mutants, pGL3 control (Promega). 
The plasmids encoding HA-ATDC and its deletion mutants were generated by 
standard PCR and subcloning. HA-ATDC K102R and K116R were generated 
using the QuickChange Site-Directed Mutagenesis kit following the 
manufacturer’s protocol (Stratagene).  HDAC9 shRNA and control shRNA was 
purchased from openbiosystem. HDAC9 shRNA and control shRNA retroviruses 
were generated by following the manufacturer’s protocol (openbiosystem).   
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Mouse affinity purified monoclonal anti-Flag M2, rabbit affinity purified 
polyclonal anti-HA, were purchased from Sigma.  Goat polyclonal anti-ATDC, 
goat polyclonal anti-p53 and mouse monoclonal anti-p53 (clone DO-1) antibodies 
were purchased from Santa Cruz Biotechnology.  Rabbit polyclonal anti-acetyl-
lysine was purchased from Upstate (Millipore).  Rabbit polyclonal anti-acetylated-
Lys382-p53 was purchased from Cell Signaling Technology. 
 
Cell Culture, Transfection, and Adenovirus Infection 
293T, HeLa, SiHa were grown in Dulbecco’s modified Eagle’s medium (DMEM) 
supplemented with 10% fetal calf serum (FCS) and penicillin/streptomycin 
(pen/strep).  The AT5BIVA cell line (GM05849) was obtained from Coriell Cell 
Repository and grown in minimum essential medium (MEM) with 10% FCS and 
pen/strep.  All transfections were normalized with equal amounts of parental 
vector DNA.  Transfections were performed with Lipofectamine 2000 (Invitrogen) 
according to the manufacturer’s instructions.  For viral infection, HeLa cells were 
infected with retrovirus for 24 h in DMEM by following the manufacturer’s protocol 
(openbiosystem). 
 
Purification of HDAC9 Containing Complex 
HeLa cells were infected with Adenovirus-HA-HDAC9-Flag or Adenovirus-GFP 
control. Affinity purification of HA- and Flag-tagged HDAC9-containing complex 
was performed according to previously published method (Rezai-Zadeh et al., 
2004). Pufified complexes were concentrated, resolved by SDS-PAGE, and 
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analyzed by silver staining. A Coomassie blue-stained sample was prepared in 
parallel, and bands corresponding to HDAC9-associated proteins were excised 
and subjected to proteolysis with trypsin. Peptides from these mixtures were 
sequenced by microcapilary LC-MS/MS. 
 
Immunoprecipitation and Western Blot Analysis 
For immunoprecipitations, cells were lysed in buffer (50 mM Tris-HCl [pH 7.5], 1 
mM EDTA, 1% NP-40, and protease inhibitor cocktail) containing either 500 mM 
NaCl (high stringency) or 150 mM NaCl (low stringency).  The lysates were 
incubated with the primary antibody overnight at 4oC.  The resultant 
immunocomplexes were collected, washed four times in lysis buffer, and 
resolved by SDS-PAGE.  For immunoblotting, samples were transferred onto 
nitrocellulose membranes.  Membranes were probed with the appropriate 
antibodies.  Proteins of interest were visualized using the Chemiluminescent 
Detection Kit (Pierce). 
 
Ion Trap Mass Spectrometry 
293T cells were transfected with the HA-ATDC expression plasmid and treated 
with TSA (1.3 M　 ) overnight.  The cells were then lysed in high stringency buffer 
containing 10 mM NaB and 10 mM nicotinamide.  Cell extracts were subjected to 
immunoprecipitation with anti-HA antibodies.  The immune complexes were 
resolved by SDS-PAGE and stained with colloidal Blue (Invitrogen).  The HA-
ATDC sequence was analyzed with an in-house algorithm (EnzOpt) for a dual 
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enzyme strategy maximizing proteotypic peptide coverage of all lysines.  The 
appropriate HA-ATDC gel band was excised and divided into two parts.  Each 
part was subjected to in-gel reduction and carboxyamidomethylation followed by 
separate tryptic or chymotryptic digestion.  Acetylated peptides from each digest 
were detected and sequenced using microcapillary reverse-phase HPLC nano-
electrospray tandem mass spectrometry (LC-MS/MS) on a Thermo LTQ linear 
quadrupole ion trap mass spectrometer.  Data analysis was facilitated with 
SEQUEST and Proteomics Browser Suite (Thermo). 
 
GST Pull-Down Assay 
GST and GST-p53 deletion mutants were expressed and purified from bacteria 
using standard methods.  Equimolar quantities of the various purified proteins 
were conjugated to glutathione-Sepharose beads and incubated with 293T cell 
(transfected with Flag-ATDC) lysates for 1 h at 4°C.  After extensive washing, 
bound proteins were eluted and analyzed by Western blotting with anti-Flag 
antibodies. 
 
Colony Survival Assay 
Colony survival assays were performed as previously described (Zhao et al., 
2002) with minor modifications.  Briefly, 24 h after transfection, cells were plated 
in quadruplicate (1,000 cells per 60-mm tissue culture dish).  The cells were γ-
irradiated with 0, 2, 2.5 or 7.5Gy as indicated.  After two weeks, dishes were 
washed with PBS, fixed in ice-cold methanol for 15 min, and then stained with 
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Giemsa stain for 30 min.  Colonies on each plate were quantified and expressed 
as the percentage of the unirradiated control. 
 
Luciferase Assay 
Luciferase assay was performed as previously described (Zhang et al., 2004). 
Briefly, U2OS cells were plated in 6-well dishes at a density of 4 x 105 cells/well. 
24hr after transfection, cells were treated as indicated in figures before harvesting 
with 250 µl of passive lysis buffer (Promega). Protein concentrations of all 
samples were determined using Bradford reagent (Bio-Rad), and the relative light 
unit values were measured with firefly assay reagent (Promega) and a 
luminometer. 
 
Immunofluorescence Assay 
Cells were washed with PBS, fixed in 4% paraformaldehyde for 10min at room 
temperature. Cells were permeabilized for 15min at room temperature using 
0.5% TritonX-100 in PBS. After blocking by 1% BSA in PBS for 30min, cells were 
incubated with primary antibody at cold room overnight, followed by Alexa-555 
and Alexa-488-conjugated secondary antibody for 1h at room temperature. Wash 
three times with PBS, dry slides, and mount slides with Bectashield mounting 
medium with DAPI. Pictures were taken using Zeiss confocal microscopy.  
 
 
 
Cell Apoptotic Assay 
Cell apoptotic assay was performed as previously described (Sawada et al., 
2003) with minor modifications.  Briefly, apoptosis was induced by γ-irradiation 
(5Gy for AT5BIVA cells and 10Gy for U2OS cells). To examine the effects of 
ATDC or HDAC9, 10  cells were cotransfected with 0.1 ug of pEGFP-C3 (GFP 
expression plasmid, Clonetech) to mark the transfected cells. The vector plasmid 
of pcDNA3.1 (+) was used as a negative control. One day after transfection, cells 
were treated with γ-irradiation. Two days after treatment, cells were stained with 
DAPI and apoptotic nuclei were counted in GFP-expressing cells under a 
fluorescence microscope (three hundred cells were counted for each 
experiment). Each point in figures showing percentages of apoptosis represents 
the mean 
5
s.e.m of three experiments.
Results 
Immunoaffinity Purification of HDAC9 Containing Complex 
To further characterization of HDAC9 biological function, we used an epitope-
tagging strategy to isolate HDAC9-containing protein complexes from human 
cells. We generated an adenovirus encoding double-tagged human HDAC9 
protein containing N-terminal HA and C-terminal Flag epitopes (HA-HDAC9-Flag) 
(Figure 8A) using the pAdEasy-1 system (He et al., 1998). To isolate protein 
complexes containing HDAC9, HeLa cells were infected with Ad-HA-HDAC9-
Flag or Adenovirus vector for 36hrs. Whole cellular extracts from the infected 
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cells were sequentially subjected to affinity chromatography on M2 (Flag 
antibody) agarose beads and an HA-affinity column. Finally, the bound proteins 
were fractionated by SDS-PAGE and visualized by silver staining (Figure 8B). A 
major protein band of 65 kDa was copurified with HDAC9 from HA-HDAC9-Flag-
expressing cells (Figure 1B, lane 2 and 4) but not from virus control cells (Figure 
8B, lane 1 and 3), suggesting that this protein is a specific binding partner of 
HDAC9. By peptide sequencing of the band using mass spectrometric analysis, it 
was identified as a known protein called ATDC (Accession # Q14134).  
ATDC Interacts with HDAC9 
To confirm the interaction between HDAC9 and ATDC, we cotransfected the 
Flag-HDAC9 and HA-ATDC plasmids transiently into 293T cells. Cell lysates 
were subsequently mixed with the anti-HA agarose and the resulting immune 
complexes were collected and analyzed by immunoblotting with the anti-Flag 
antibody (Figure 8C). As indicated in Figure 8C, immunoprecipitation of HA-
ATDC from lysates of these cotransfected cells resulted in coprecipitation of 
Flag-HDAC9. We also detected this interaction reciprocally by using the anti-Flag 
antibody for immunoprecipitation and anti-HA antibody for probing of the blotted 
precipitate (Figure 8D). These observations provided the first indication that 
HDAC9 and ATDC can form physical complexes with one another in vivo. 
To investigate the interaction between endogenous HDAC9 and ATDC, 
cell extracts from HeLa cells were immunoprecipitated with anti-ATDC or with the 
 A C Adenovirus-HA-HDAC9-Flag Input            +       -        - 
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Figure 8. Immuno-affinity purification of HDAC9 containing complex 
(A) Scheme of the Adenovirus-HA-HDAC9-Flag. (B) Purification of the HDAC9-containing complexes. HA-FLAG-epitope-
tagged HDAC9 was purified from HeLa cells infected with adenovirus expressing HA-HDAC9-FLAG by 
immunoprecipitation with antibody specific for FLAG (lane 2), followed by antibody specific for HA (lane 4). As a control, 
mock purification was performed from HeLa cells infected with adenovirus expressing GFP alone (lanes 1 and 3). Specific 
HDAC9-interacting protein bands were peptide sequenced by mass spectrometry. (C, D) 293T cells were co-transfected 
with plasmids (4ug each) encoding the indicated HA and Flag fusion proteins.  Anti-HA and anti-Flag immunoprecipitates 
obtained under low stringency conditions were analyzed by Western blotting with the indicated antibodies.  (E, F) 
Endogenous ATDC or HDAC9 were immunoprecipitated from HeLa cell lysates under low stringency conditions with anti-
ATDC or anti-HDAC9 polyclonal antibodies.  Immune complexes were analyzed by Western blotting with indicated 
antibodies. (G) 293T cells were co-transfected with HA-ATDC and Flag-HDAC9 or its deletion mutants. Anti-Flag 
immunoprecipitates obtained under low stringency conditions were analyzed by Western blotting with anti-HA antibody. 
 
control IgG. As expected, Western blot analysis revealed that HDAC9 was clearly 
detected in the immunoprecipitations obtained with the anti-ATDC antiserum 
(Figure 8E) but not the control IgG (Figure 8E). Conversely, endogenous ATDC 
was readily immunoprecipitated with the HDAC9-specific antibody (Figure 8F), 
but not with a control IgG (Figure 8F). These data indicate that HDAC9 and 
ATDC could form a physical complex in vivo.  
To further investigate how ATDC interacts with HDAC9, we generated 
several HDAC9 deletion mutants. HA-ATDC and Flag-HDAC9 deletion mutants 
were cotransfected into 293T cells. Cell lysates were immunoprecipitated with 
anti-flag agarose. As shown in Figure 8G, ATDC specifically bound to HDAC9 C-
terminal domain (HDAC9 601-1011aa) (Figure 8G), but not to Flag vector control, 
the N-terminal domain of HDAC9 (1-350aa) and the central domain (HDAC9 351-
600). Thus, the above findings demonstrate that ATDC interacts with mammalian 
HDAC9 deacetylase in vivo. 
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ATDC is an Acetylated Protein  
Since HDAC9 could form physical complexes with ATDC, we sought to 
determine whether ATDC could serve as a substrate of HDAC9 enzyme. Firstly, 
we examined whether ATDC could be modified by acetylation. 293T cells were 
transfected with the plasmid encoding HA-ATDC. 24hrs post transfection, cells 
were incubated with ethanol carrier or HDAC chemical inhibitors trichostatin (TSA) 
overnight. We then immunoprecipitated HA-ATDC from these cells and analyzed 
the immune complex by western blotting using an antibody previously shown to 
recognize acetylated lysines in viarious proteins. As shown in figure 9A, 
treatment with TSA significantly enhances ATDC acetylation. Anti-acetyl-lysine 
Western blot analysis of anti-ATDC immunoprecipitates revealed that TSA also 
could enhance the acetylation state of endogenous ATDC (Figure 9B). To map 
the ATDC lysine-acetylation sites induced by TSA, tandem mass spectrometry 
analysis was performed. We found that at least 9 lysine sites of ATDC was 
acetylated (Figure 9C). These data strongly sugested that ATDC was an 
acetylated protein within cells. 
 
ATDC Acetylation is Regulated by HDAC9 
It is well known that the histone acetyltransferases PCAF and p300 target 
nonhistone proteins for acetylation (Glozak et al., 2005; Kouzarides, 2000; Yang, 
2004). So, we co-transfected 293T cells with vectors expressing HA-ATDC and 
Flag-PCAF or HA-P300. The cell lysates were then analyzed by 
immunoprecipitation using anti-HA agarose followed by western blotting using  
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Figure 9. ATDC is an acetylated protein which is regulated by HDAC9  
(A) 293T cells were transfected with plasmids that expressed HA-ATDC (4ug).  Twenty-four hours post-transfection, cells 
were left untreated or treated overnight with TSA (1.3uM).  Cell lysates were subjected to immunoprecipitation/Western 
blotting. (B) HeLa cells were treated with TSA (1.3uM) or left untreated overnight.  Cell lysates were then 
immunoprecipitated under high stringency conditions with anti-ATDC antibodies.  Endogenous acetylated ATDC was 
analyzed by Western blotting with a mixture of polyclonal anti-acetyl-lysine antibodies. (C) HA-ATDC, which was 
expressed and purified from 293T cells, was digested with trypsin and subjected to ITMS.  Positions of the 
unambiguously-identified acetylated lysine residues are shown.  (D) 293T cells were co-transfected with equal amounts 
(4ug) of HA-ATDC ± one of the following expression plasmids: Flag-PCAF, or HA-p300.  Cell lysates were 
immunoprecipitated (IP) under high stringency conditions using anti-HA antibodies. Immunoprecipitates were subjected to 
Western blot (IB) analysis using anti-acetyl-lysine (AcK) antibodies.  The blot was stripped and re-probed with anti-HA 
antibodies to confirm equal immunoprecipitation efficiency and loading. Flag-PCAF and HA-P300 expression were 
detected in the cell lysate. (E) 293T cells were co-transfected with plasmids that express HA-ATDC, HA-P300, and either 
a vector or a Flag-HDAC9.  Acetylation of HA-ATDC and all protein levels were determined with direct Western blotting or 
immunoprecipitations followed by Western blotting using the indicated antibodies.   (F) HeLa cells were infected with 
either retrovirus that expresses control siRNA or retrovirus that expresses HDAC9 shRNA.  Western blots were performed 
with the indicated antibodies to assess the acetylation of endogenous ATDC and ATDC immunoprecipitation efficiency. 
Bottom two panels, western blot to show that HDAC9 shRNA is functional. 
 
anti-acetyl lysine antibody. Acetylated ATDC was readily detected with co-
expression of P300, but not with PCAF acetyltransferase (Figure 9D). We found 
ATDC also could interact with p300 within cells (data not shown). 
To further address ATDC acetylation was regulated by HDAC9, we 
transfected 293T cells with HA-ATDC, P300 and Flag vector or Flag-HDAC9. 
HA-ATDC was immunoprecipitated and followed by anti-acetyl lysine western 
blotting. As shown in figure 9E, a high level of acetylated ATDC was found in the 
cells cotransfected with P300 and HA-ATDC (Figure 9E, lane 1); however, p300-
mediated ATDC acetylation levels were significantly decreased by expression of 
Flag-HDAC9 (Figure 9E, lane 2). Furthermore, we assessed the ATDC 
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acetylation in HDAC9 knock-down cells by immunoprecipitating endogenous 
ATDC and immunoblotting with antibodies to acetylated lysine (Figure 9F). 
Acetylation of endogenous ATDC was enhanced in HDAC9 knock-down cells 
compared to control shRNA cells (Figure 9F), suggesting that endogenous 
HDAC9 does influence ATDC acetylation in vivo. As indicated in Figure 9F, 
endogenous HDAC9 protein levels were reduced by the sequence-specific 
HDAC9 shRNA but not by control shRNA (Figure 9F, bottom panel). Taken 
together, these data implicate a strong ATDC deacetylation activity of HDAC9 
deacetylase. Acetylation of ATDC was barely detectable in the absence of 
HDAC9 inhibiotr TSA or exogenous acetyltransferase p300 (Figure 9A and 9D), 
possibly owing to the limiting amounts of endogenous p300 acetytransferase 
activity, or ATDC preferentially forming a stable complex with the HDAC9 
deacetylase. 
HDAC9 has multiple isoforms (Petrie et al., 2003). To test whether ATDC 
has HDAC9 isoform preference binding capability, 293T cells were cotransfected 
with the plasmids encoding HA-ATDC and Flag-tagged all known HDAC9 
isoforms (Petrie et al., 2003). Cell lysates were immunoprecipitated with anti-flag 
agarose, and then analyzed with anti-HA antibody. As shown in figure 10A, 
ATDC preferentially bound to HDAC9-PNAS, and weakly bound to HDAC9∆E7, 
but not the other HDAC9 isofroms. Correlated with the binding preference, 
deacetylation of ATDC by HDAC9 might be also highly isoform-specific since 
only HDAC9-PNAS shows strong deacetylase activity to ATDC (Figure 10B, lane 
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2), but not other HDAC9 isoforms we tested (HDAC9∆E7 or HDAC9-JBC) 
(Figure 10B, lane 3 and 4).   
HDAC7 and HDAC9 were further subdivided into the class IIa HDAC 
based on their homology (Gray et al., 2001). As indicated in figure 10C, the 
ATDC-HDAC9 interaction might also be highly HDAC specific since HDAC7 did 
not co-precipitate with ATDC under identical conditions (Figure 10C). 
Furthermore, p300-acetylated ATDC was specifically deacetylated by HDAC9 
(Figure 10D, lane 3), but not by HDAC7 (Figure 10D, lane 2). 
HDAC9 Negatively Regulates ATDC Biological Function 
ATDC was cloned and coined by its ability to complement the radiosensitivity 
defect of the AT5BIVA fibroblast cell line. To observe the effect of HDAC9 on its 
function, AT5BIVA cells were transfected with vector alone, HA-ATDC alone,  
Flag-HDAC9 alone or HA-ATDC and Flag-HDAC9 expression constructs. As 
expected, cell colony survival assay suggested ATDC could complement the 
AT5BIVA cell radiosensitivity defect (Figure 11A, compare column 1 and 3). 
Interestingly, HDAC9 coexpression significantly antagonize the ATDC function, 
with about 25.00% of the cell survival compared with about 47.00% of ATDC 
alone-complemented cells (Figure 11A, compare column 3 and 4).  
It has been reported that γ-irradiation could induce cell apoptosis to a 
greater extent in AT5BIVA cells than in control fibroblast cell lines (Zhang et al., 
2001; Jung et al., 1998). Combining the fact that ATDC could provide AT5BIVA  
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Figure 10. ATDC acetylation is preferentially regulated by HDAC9 
(A, C) 293T cells were co-transfected with plasmids (4ug each) encoding the indicated HA and Flag fusion proteins.  Anti-
HA and anti-Flag immunoprecipitates obtained under low stringency conditions were analyzed by Western blotting with 
the indicated antibodies. HDAC9 isoforms used in panel A: 1. Vector Control; 2. HDAC9-PNAS; 3. HDAC9-JBC; 4. 
HDAC9∆CD; 5. HDAC9∆E7; 6. HDAC9∆CD∆E7; 7. HDAC9∆E12; 8. HDAC9∆E15. HDAC9-PNAS represents the first 
reported-HDAC9 gene product on PNAS in 2001, and this is the one we used to purify the HDAC9 containing complex. 
HDAC9-JBC represents the longest HDAC9 isoform published on JBC in 2003. (B, D) 293T cells were co-transfected with 
equal amounts (4ug) of HA-ATDC ± the HA-p300 expression plasmid. Cell lysates were immunoprecipitated (IP) under 
high stringency conditions using anti-HA antibodies. Immunoprecipitates were subjected to Western blot (IB) analysis 
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using anti-acetyl-lysine (AcK) antibodies.  The blot was stripped and re-probed with anti-HA antibodies to confirm equal 
immunoprecipitation efficiency and loading. HA-P300 and HDACs expression were detected in the cell lysate. 
 
cells a radioresistant phenotype (Kapp et al., 1992; Hosoi et al., 1994), it’s 
interesting to hypothesize that ATDC might facilitate AT5BIVA cell survival by 
inhibiting γ-irradiation induced-cell death. To test this idea, apoptosis assay was 
carried out in AT5BIVA cells by expressing vector alone, HA-ATDC alone, Flag-
HDAC9 alone or HA-ATDC and Flag-HDAC9. As shown in figure 11B, ATDC 
significantly decreases the IR-induced AT5BIVA cell apoptosis (Figure 11B, 
compare column 1 and 3). However, introduction of HDAC9 could strongly 
reverse the ATDC anti-apoptotic function (Figure 11B, compare column 3 and 4). 
A parallel western blot shows HDAC9 does not affect the HA-ATDC expression 
in cells (Figure 11A, right panel). 
 
ATDC Antagonizes p53-mediated Apoptotic Pathway Activated by γ-
irradiation and Forms a Physical Complex with p53 
P53 has been shown to be important for γ-irradiation-induced apoptosis (Lee et 
al., 2001; Herzog et al., 1998; Chong et al., 2000). Next, we examined the effect 
of ATDC on p53-mediated apoptotic pathway. As indicated in figure 12A, ATDC 
transfected-U2OS (wild type p53+/+) cells were more resistant to γ-irradiation 
induced-cell death, with about 22.3% of the cells apoptosis while the vector 
control-transfected cells showed significantly susceptible to apoptosis under the 
same conditions (Figure 12A, compare column 1 and 2). Furthermore, the same 
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Figure 11. HDAC9 negatively regulates ATDC biological function 
(A) Left panel, AT5BIVA cells transfected with plasmids (4ug each) encoding the indicated proteins were irradiated (2Gy) 
or left unirradiated. The surviving colonies were counted two weeks later.  Right panels, direct Western blots were 
performed to determine protein expression levels. Representative blots are shown. (B) AT5BIVA cells were transfected as 
indicated (see Methods). One day after transfection, cells were irradiated (10Gy). After a further 48h, the number of 
apoptotic cells was counted in GFP+ cells.  
 
experiments were performed in the human p53 null cell line H1299. No significant 
effect was observed on H1299 cells (Figure 12A, compare column 3 and 4). 
These data suggested that ATDC could facilitate cell survival by antagonizing the 
p53-mediated apoptotic pathway activated by γ-irradiation. 
To further explore the molecular mechanism by which ATDC affects p53 
function, we tested whether ATDC interacts with p53 in vivo. 293T cells (wild type 
p53+/+) were transfected with HA-ATDC plasmid. Cell lysates were subsequently 
mixed with the anti-HA agarose and the resulting immune complexes were 
collected and analyzed by immunoblotting with the p53-specific monoclonal 
antibody (DO-1) (Figure 12B). As shown in figure 12B, immunoprecipitation of 
HA-ATDC from lysates of these transfected cells resulted in coprecipitation of 
endogenous p53. However, γ-irradiation doesn’t affect the ATDC-p53 complex 
formation. These observations provided the first indication that ATDC and p53 
can form physical complexes with one another in vivo. This association of ATDC 
and p53 also occurs in the absence of overexpression, epitope tagging of either 
protein in SiHa cells (Figure 12C), which express both endogenous ATDC and 
wild-type  
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Figure 12. ATDC facilitates cell survival by antagonizing p53-mediated apoptotic pathway activated by g-
irradiation and ATDC forms a physical complex with p53 
(A) U2OS and H1299 cells were transfected as indicated (see Methods). One day after transfection, cells were irradiated 
(10Gy). After a further 48h, the number of apoptotic cells was counted in GFP+ cells. (B) 293T cells were transfected with 
HA-ATDC.  24hrs post transfection, cells were irradiated (10Gy) or left untreated.  One hour after irradiation, HA-ATDC 
was immunoprecipitated under low stringency conditions with anti-HA agarose.  Immune complexes were analyzed by 
Western blotting with p53 antibody DO-1. (C) Endogenous ATDC was immunoprecipitated from SiHa cell lysates under 
low stringency conditions with goat anti-ATDC polyclonal antibodies. Immune complexes were analyzed by Western 
blotting with p53 antibody DO-1. (D) 293T cells were transfected with HA-ATDC or its deletion mutants. Anti-HA 
immunoprecipitates obtained under low stringency conditions were analyzed by Western blotting with p53 antibody DO-1. 
 
p53 proteins. Analyses of three different HA-ATDC deletions indicated that p53 
preferentially interacts with the N-terminus of ATDC (residues 1-200) (Figure 
12D). 
 
ATDC Inhibit p53 Function by Sequestering p53 into the Cytoplasm 
ATDC mainly located in the cytoplasm (Laderoute et al., 1996; Brzoska et al., 
1995; Reymond et al., 2001). To further confirm the ATDC subcellular 
localization, U2OS cells were transfected with the plasmid encoding HA-ATDC, 
and immunofluorescence study was carried out. Consistent with the previous 
findings (Brzoska et al., 1995; Reymond et al., 2001), HA-ATDC was found in the 
cytoplasm in a ribbon-like structure (Figure 13A). Endogenous ATDC was also 
found in the cytoplasm in SiHa cells (Figure 13B) and pancreatic carcinoma 
tissues (Figure 13C). Since ATDC involves in regulating p53-mediated apoptotic 
pathway, it’s intriguing to test whether ATDC directly controls subcellular 
localization of p53. To test this idea, U2OS cells were transfected with HA-ATDC.  
 A HA-ATDC DAPI Merged 
 
 
 
 
B ATDC Merged DAPI 
 
 
 
 
 C 
 
 
 
 
 
 
Figure 13. ATDC is a cytoplasmic protein 
(A) U2OS cells were transfected with HA-ATDC. 24hr post transfection, cells were fixed, permeabilized, and 
immunostained with anti-HA antibody. (B) SiHa cells were fixed, permeabilized, and immunostained with anti-ATDC 
antibody, followed by Alexa-555 secondary antibody. (C) Pancreatic carcinoma tissue samples were stained with anti-
ATDC antibody. 
 
As shown by immunofluorescence staining with the p53-specific antibody DO-1 
(Figure 14A, inset), p53 mainly located in the nucleus in the absence of 
overexpressed-ATDC. Strikingly however, after overexpression of ATDC, p53 
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was predominantly relocalized to the cytoplasm of these cells and displayed a 
similar pattern as ATDC (Figure 14A). Similar results were also obtained in the 
cells treated with γ-irradiation (Figure 14A, bottom panel). These data indicated 
that forced-expression of ATDC could control p53 subcellular localization even 
under stress. To test the effect of ATDC on endogenous p53 transcriptional 
activity, U2OS cells were transfected with the p53-responsive BP100-luciferase 
reporter and different dosage of plasmid encoding HA-ATDC. P53 transcription 
function was measured by luciferase assay. As shown in figure 14B, ATDC 
shows strong inhibition of endogenous p53 transcriptional activity (Figure 14B) in 
a dose dependent manner. The inhibitory effect of ATDC on p53 responsive 
promoter is quite specific, since the pGL3 control reporter was not affected by 
ATDC. ATDC even shows similar strong inhibitory effect on p53 transcriptional 
activity  under stress response (Figure 14C). 
 
HDAC9 Regulates the ATDC-p53 Complex Formation and Function 
Since ATDC is a HDAC9 substrate as an acetylated protein, it is interesting to  
address whether HDAC9 could regulate the ATDC-p53 complex formation. To 
test this idea, 293T cells were transfected with vector, HA-ATDC alone or HA-
ATDC and Flag-HDAC9. The cell lysates were immunprecipitated with anti-HA 
agarose and the resulting immune complexes were collected and analyzed by 
immunoblotting with the goat anti-p53 polyclonal antibody. Consistent with the 
above results, ATDC could efficiently pull-down endogenous p53 (Figure 15A, 
lane 2). However, HDAC9 could significantly inhibit the ATDC and p53 interaction  
 A IR 
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Figure 14. ATDC inhibits p53 function 
(A) U2OS cells were transfected with HA-ATDC. 24hr post transfection, cells were left untreated or treated with 10Gy γ-
irradiationn. 1hr after treatment, cells were fixed, permeabilized, and stained with anti-HA and anti-p53 DO-1 antibody, 
followed by Alexa-555 and Alexa-488-conjugated secondary antibodies. Samples were analyzed using Zeiss Confocal 
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Microscopy. (B) U2OS cells were transfected as indicated. Luciferase activities were determined in triplicate. Error bars 
show standard deviations. (C) U2OS cells were transfected as indicated. 24hr post transfection, cells were left untreated 
or treated with 10Gy γ-irradiation. 4hr after treatment, cells were harvested and luciferase activities were determined in 
triplicate. Error bars show standard deviations. 
 
(Figure 15A, compare lane 3 and 2). Further, treatment with HDAC inhibitor TSA 
could significantly enhance the ATDC-p53 complex formation (Figure 15B, 
compare lane 2 and 3). These data suggested that acetylated form of ATDC 
preferentially interacts with p53 in cells.  
Correlated with the above results, TSA treatment could significantly 
increase the ATDC suppressive effect on endogenous p53 transcriptional activity 
(Figure 15C). Furthermore, expression of p21, a major transcriptional target of 
p53, was significantly induced by ATDC-specific siRNA (Figure 15D, left panel) 
or by overexpression of HDAC9 (Figure 15D, right panel) in SiHa cells although 
the total level of p53 was unchanged.  
 
ATDC K116 Acetylation is the Major Functional Acetylation Site 
Responsible for Regulating p53 Interaction  
Two acetylation sites of ATDC (K102 and K116) located in the p53 binding 
domain (ATDC 1-200aa) (Figure 9C and 12D).  By aligning the protein sequence 
among several known vertebrates ATDC homologous (human, chimpanzee, 
mouse, rat and dog) (Figure 16A), we found that lysine 102 was replaced by 
arginine in mouse and rat ATDC. Since arginine mutation could mimic the non- 
acetylated form of lysine (Chan et al., 2001), this suggests K102 acetylation 
TSA              -        -       + B  F-HDAC9      -       -      + A HA-ATDC     -       +      + 
HA-ATDC     -      +      + 
HA IP 
  p53 p53 IB HA IP 
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Figure 15. HDAC9 regulates the ATDC-p53 complex 
(A) 293T cells were co-transfected with HA-ATDC and Flag-HDAC9 or control vector. Anti-HA immunoprecipitates 
obtained under low stringency conditions were analyzed by Western blotting with p53 antibody DO-1 and anti-Flag. (B) 
293T cells were transfected with HA-ATDC. 24hr post transfection, cells were treated with 1.3uM TSA overnight. Anti-HA 
immunoprecipitates obtained under low stringency conditions were analyzed by Western blotting with p53 antibody DO-1. 
(C) U2OS cells were transfected as indicated. 24hr post transfection, cells were treated with ethanol carrier or 1.3uM TSA 
overnight. Cells were harvested and luciferase activities were determined in triplicate. Error bars show standard 
deviations. (D) U2OS cells were transfected or infected as indicated. 48hr post transfection or infection, cells were 
harvested, and cell lysates were analyzed as indicated.  
 
might not play an important role in regulating ATDC function. However, K116 in 
ATDC was quite well conserved, suggesting it might be an important functional 
acetylation site.  To test this idea, human ATDC K102 and K116 were mutated to 
arginine, individually. As shown in figure 16, mutating lysine 116 to argine 
significantly decrease ATDC-p53 complex formation and p53 cytoplasm 
sequestration (Figure 16B). However, there is no effect by mutating human lysine 
102 to arginine. Further, K116R mutant could abolish the ATDC inhibitory effect 
on p53 transcriptional activity (Figure 16C). Interestingly, K116R mutant also 
abolish the ability of ATDC to complement the radiosensitivity of AT5BIVA cells, 
but not by K102R mutant (Figure 16D). These data suggested that ATDC 
biological function was dynamically controlled through K116 acetylation. However, 
the function of other acetylation sites of ATDC is still not understood yet.  
 
ATDC was Overexpressed in Pancreatic and Cervical Carcinoma 
It was reported that mRNA of ATDC was significantly amplified in pancreatic 
carcinoma and cervical carcinoma (Iacobuzio-Donahue et al., 2002; Zhang et al.  
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Figure 16. ATDC K116 acetylation play a major role in regulating ATDC-p53 interaction 
(A) Alignment of ATDC homologous including human, chimpanzee, mouse, rat and dog. (B) U2OS cells were transfected 
as indicated. 36hr post transfection, cells were fixed, permeabilized, and stained with anti-HA and anti-p53 DO-1 antibody, 
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followed by Alexa-555 and Alexa-488-conjugated secondary antibodies. Samples were analyzed using Zeiss Confocal 
Microscopy. (C) U2OS cells were transfected as indicated. 36hr post transfection, cells were harvested and luciferase 
activities were determined in triplicate. Error bars show standard deviations. Statistical analysis was done by student t 
test. Fractions of lysates were analyzed by western blot to check protein expression. (D) AT5BIVA cells transfected with 
plasmids (4ug each) encoding the indicated proteins were irradiated (2Gy) or left unirradiated. The surviving colonies 
were counted two weeks later.   
 
2005). As previous shown in figure 13C, ATDC protein is also highly expressed 
in pancreatic carcinoma tissue. Similarly, the ATDC protein is also highly 
expressed in the pancreatic carcinoma cell lines that we tested, including 
Hs766T and BxPC3, and cervical carcinoma cell lines including HeLa and SiHa 
(Figure 17A) compared to other tumor cell lines. By immunostaining study, we 
found endogenous ATDC colocalized with endogenous p53 in the cytoplasm in 
SiHa cell line (wild-type p53+/+) (Figure 17B). Nevertheless, RNAi-mediated 
reduction of endogenous ATDC leads to nuclear localization of p53 in SiHa cells 
(Figure 17C). Fruthermore, we tested whether shRNA-mediated inhibition of 
ATDC function could radio-sensitize cervical carcinomal cells. As indicated in 
figure 17D, native SiHa cervical carcinoma cells responded poorly to treatment 
with γ-irradiation. However, treatment with ATDC shRNA significantly makes the 
cells more susceptible to irradiation treatment. SiHa cells were also sensitized by 
overexpression of HDAC9, probably through antagonizing the endogenous 
ATDC function. Furthermore, shRNA-mediated reduction of ATDC and forced- 
expression of HDAC9 have an additive effect on SiHa cell radiosensitivity when 
treated with high dosage of γ-irradiation (7.5Gy) (Figure 17D). Thus, the 
combination of knocking-down ATDC expression and introduction of HDAC9 
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Figure 17. Endogenous ATDC in cervical carcinoma cells regulates p53 nuclear localization and function
(A) ATDC is highly expressed in pancreatic and cervical carcinoma cell lines. Whole-cell extracts of different cell lines 
were immunoblotted with anti-ATDC antibody (upper) and anti-actin antibody (lower). (1.HCT116; 2. U2OS; 3. Hs766T; 4. 
CAPAN-2; 5. Bx-PC3; 6. AT5BIVA; 7. HeLa; 8. 293T; 9. SiHa; 10. A549; 11. COLO357). (B) SiHa cells were fixed, 
permeabilized, and stained with anti-ATDC and anti-p53 DO-1 antibodies, followed by Alexa-555 and Alexa-488-
conjugated secondary antibodies, and analyzed using Zeiss Confocal Microscopy. (C) SiHa cells were transfected with 
control or ATDC siRNA. 48 hr post transfection, cells were fixed, permeabilized, and stained with anti-ATDC and anti-p53 
DO-1 antibodies, followed by Alexa-555 and Alexa-488-conjugated secondary antibodies, and analyzed using Zeiss 
Confocal Microscopy. (D) SiHa cells transfected or infected as indicated. 48hr post transfection or infection, cells were 
irradiated (2.5 or 7.5Gy) or left unirradiated. The surviving colonies were counted 10 days later.   
 
might be an alternative treatment for the radio-resistant tumors caused by 
amplified ATDC expression.  
 
Growth Stress Induce ATDC Acetylation 
Since ATDC plays an important role in regulating p53-mediated apoptotic 
pathway and might have a significant effect on the clinical radio-therapy for 
tumors, it is tempting to identify the physiological conditions under which ATDC 
are highly acetylated in cells. We treated cervical carcinoma cells with various 
extracellular stimuli and performed Western blot experiments with antibodies to 
acetylated lysine. As shown in figure 18A and 18B, acetylation of endogenous 
ATDC in HeLa cells is dynamically inducible in response to growth factors 
stimulation including EGF (Figure 18A) and PMA (Figure 18B). In contrast, ATDC 
acetylation was not affected by γ-irradiation (data not shown). Thus, ATDC 
acetylation appears to be specifically induced in response to growth stress 
stimuli. Similar results were obtained in SiHa cells treated with PMA (Figure 18C). 
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Figure 18. Growth stress regulates ATDC acetylation 
(A) HeLa cells were starved for 18hr, and treated with EGF (100ng/ml) or left untreated as indicated.  Cell lysates were 
then immunoprecipitated under high stringency conditions with anti-ATDC antibodies.  Endogenous acetylated ATDC was 
analyzed by Western blotting with a mixture of polyclonal anti-acetyl-lysine antibodies. (B) HeLa cells were starved for 
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18hr, and treated with PMA (50ng/ml) or left untreated as indicated.  Acetylation of endogenous ATDC was analyzed as in 
Panel A. (C) SiHa cells were starved for 18hr, and treated with PMA (50ng/ml) or left untreated as indicated.  Acetylation 
of endogenous ATDC was analyzed as in Panel A. (D) SiHa cells were starved for 18hr, and treated with PMA (50ng/ml) 
or left untreated as indicated. Cells were fixed, permeabilized, and stained with anti-ATDC and anti-p53 DO-1 antibodies, 
followed by Alexa-555 and Alexa-488-conjugated secondary antibodies, and analyzed using Zeiss Confocal Microscopy. 
 
Interestingly, we found that ATDC interacts with p53 in SiHa cell cytoplasm in a 
growth stress-inducible manner (Figure 18D), which could be correlated with 
growth stress-induced ATDC acetylation (Figure 18C). These data suggested 
that ATDC acetylation, which could be regulated by growth factors in tumor 
microenvironment, might be helpful for tumor cells to resist ionizing radiation 
therapy and survive. 
Dissussion 
The present data reveal that ATDC, the product of the ataxia-telangiectasia 
group D complementing gene, is acetylated dynamically within the cells in a 
growth stress stimulation manner. And HDAC9 and p300 acetyltransferase as its 
interaction partners play important roles to balance ATDC reversible acetylation. 
Importantly, ATDC is a cytoplasmic protein that is critically involved in the 
regulation of p53 subcellular localization and subsequent function in cells. 
HDACs play critical roles in diverse biological functions (Ruijter et al., 2003; 
Marks et al., 2003). The HDAC9 mutant mice displays an enhanced response to 
stress signals and enhanced hypertrophic phenotype (Zhang et al., 2002), 
suggesting this HDAC acts in the adult heart to suppress the fetal gene program 
and hypertrophic growth. And this function was carried out by forming a complex 
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with an important transcription factor MEF2 (the myocyte enhancer-binding factor 
2) (Zhang et al., 2002; Haberland et al., 2007). In this study, using immunoaffinity 
purification method, we identify another important HDAC9 interaction partner 
ATDC. Through preventing the ATDC-p53 complex formation, HDAC9 could 
sensitize the tumor cells with a radio-resistant phenotype caused by abnormal 
expression of ATDC. These data would have an important implication for future 
clinical radio-therapy for cancer.  
The molecular basis of the defect in AT is still largely unknown, although the 
diversity of phenotypes has led to the suggestion that a signaling mechanism 
may be defective. ATDC, which complements the ionizing radiation sensitivity of 
AT group D cell lines, might involve in a signal transduction pathway that is 
induced by ionizing radiation. It has been previously reported that it could 
physically interact with vimentin, a type III intermediate filament; with hPKCI-1, a 
small protein inhibitor of PKC (Brzoska et al., 1995). Some experiments data 
suggested aberrant p53 function may be a major factor in the hypersensitivity of 
AT cells to ionizing radiation (Meyn et al., 1994). In the current study, ATDC was 
found it could physically interact and colocalize with p53 in the cell cytoplasm. By 
controlling p53 subcellular localization and its subsequent biological function, 
ATDC could facilitate the cell survival under γ-irradiation stress. Taken together, 
these data suggest a model in which ATDC-p53 complex involves in an ionizing 
radiation-induced signal transduction pathway.  
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As a transcription factor, nuclear localization of p53 is essential for its role in 
tumor suppression (Vousden et al., 2002; Jimenez et al., 1999). However, p53 is 
diffusely distributed in the cytoplasm of normal unstressed cells; many types of 
tumors cells have abnormal cytoplasmic localization of p53 and an impaired p53-
dependent stress response despite the fact that they express wild-type p53 
proteins (Jimenez et al., 1999; Moll et al., 1996). In previous studies, it has been 
shown that the majority of cytoplasmic p53 is tightly associated with endogenous 
Parc (p53-associated, Parkin-like cytoplasmic protein) (Nikolaev et al., 2003). In 
the absence of stress, inactivation of endogenous Parc leads p53 activation 
through inducing p53 nuclear localization. In current study, ATDC was also found 
has a similar role as Parc in regulating p53 function. Furthermore, ATDC-p53 
complex formation is regulated by ATDC K116 acetylation, which is controlled by 
HDAC9. And our results also indicate that the levels of ATDC proteins are 
relatively high in cervical and pancreatic carcinoma cell lines and pancreatic 
tumor tissues. It is conceivable, therefore, that the high levels of ATDC in these 
cells may prevent nuclear translocation of p53, even in the presence of genotoxic 
stress although other mechanisms may also contribute to this phenomenon. In 
consistence with this notion, we have also shown that shRNA-mediated reduction 
of ATDC protein levels or introduction of HDAC9 can restore a strong p53-
dependent stress response in cervical carcinoma SiHa cells. As such, the ATDC-
mediated pathway of p53 regulation may prove to be a potential target for cancer 
therapy. In particular, agents that down-regulate ATDC protein levels or abrogate 
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the ATDC-p53 interaction, such as introduction of HDAC9, may sensitize tumor 
cells to p53-dependent apoptosis. 
As an acetylated protein, p53 function was directly regulated by a class I HDAC, 
HDAC1 (Luo et al., 2000), and a class III HDAC, SIRT1 (Luo et al., 2001; Vaziri 
et al., 2001). In current study, we report a class II HDAC, HDAC9 could indirectly 
regulate p53-mediated apoptotic pathway by regulating its interaction with ATDC. 
These data suggest HDACs play much wider roles in cells in addition to their 
transcriptional repression function.    
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